The global Hemoglobin A1c Testing Devices Market was valued at USD 1.4 Billion in 2023 and is projected to reach more than USD 3.3 Billion by the end of 2034, expanding at a CAGR of 7.7% from 2024 to 2034. Rising diabetes prevalence, increasing emphasis on regular blood glucose monitoring, growing demand for point-of-care diagnostics, and technological advancements in HbA1c testing devices are...